- Knowledge Base
- Guides
- Glossary
- Q&A
- Documentation
- Blog
- For Small Business
- For Capture Teams
- Compare Platforms
- Services
- Workflow Automation
- Support
- Contact Us
© Copyright 2026 Gov Contract Finder.
This federal contract opportunity has been awarded to on January 27, 2026.
This solicitation resulted in an award to for approximately $38,750 on January 27, 2026. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541380 (Testing Laboratories and Services).
This is a Firm Fixed Priced purchase order. NCI solicited and negotiated directly with Charles River Discovery Research Services UK Limited. The National Cancer Institute (NCI) has a program to use an antibody called, 'A10' to target cancer cells that have a lot of the epidermal growth factor receptor on their cell surface. While this antibody has been extensively tested and characterized it is not known if it also binds any other cell surface proteins. The contractor shall perform an off-target screen on an NCI antibody and report back on any problematic interactions that could predict a serious side effect should the antibody be given to a cancer patient. The A10 is NOT known to bind other cell surface proteins or secreted proteins but this needs to be addressed in the off-target screen.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for testing laboratories and services with a set-aside for No Set Aside businesses in ROCKVILLE, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Looking for more opportunities?
Browse our full directory of government contracts